152 related articles for article (PubMed ID: 23852468)
21. Bias-reduced and separation-proof GEE with small or sparse longitudinal binary data.
Mondol MH; Rahman MS
Stat Med; 2019 Jun; 38(14):2544-2560. PubMed ID: 30793784
[TBL] [Abstract][Full Text] [Related]
22. Mechanistic Multiscale Pharmacokinetic Model for the Anticancer Drug 2',2'-difluorodeoxycytidine (Gemcitabine) in Pancreatic Cancer.
Garcia-Cremades M; Melillo N; Troconiz IF; Magni P
Clin Transl Sci; 2020 May; 13(3):608-617. PubMed ID: 32043298
[TBL] [Abstract][Full Text] [Related]
23. Extended methods for gene-environment-wide interaction scans in studies of admixed individuals with varying degrees of relationships.
Chen Y; Adrianto I; Ianuzzi MC; Garman L; Montgomery CG; Rybicki BA; Levin AM; Li J
Genet Epidemiol; 2019 Jun; 43(4):414-426. PubMed ID: 30793815
[TBL] [Abstract][Full Text] [Related]
24. Methods for interaction analyses using family-based case-control data: conditional logistic regression versus generalized estimating equations.
Hancock DB; Martin ER; Li YJ; Scott WK
Genet Epidemiol; 2007 Dec; 31(8):883-93. PubMed ID: 17565751
[TBL] [Abstract][Full Text] [Related]
25. An improved quadratic inference function for parameter estimation in the analysis of correlated data.
Westgate PM; Braun TM
Stat Med; 2013 Aug; 32(19):3260-73. PubMed ID: 23280875
[TBL] [Abstract][Full Text] [Related]
26. Sequence robust association test for familial data.
Dai W; Yang M; Wang C; Cai T
Biometrics; 2017 Sep; 73(3):876-884. PubMed ID: 28273695
[TBL] [Abstract][Full Text] [Related]
27. Candidate-gene association studies with pedigree data: controlling for environmental covariates.
Slager SL; Schaid DJ; Wang L; Thibodeau SN
Genet Epidemiol; 2003 May; 24(4):273-83. PubMed ID: 12687644
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide gene-environment interactions on quantitative traits using family data.
Sitlani CM; Dupuis J; Rice KM; Sun F; Pitsillides AN; Cupples LA; Psaty BM
Eur J Hum Genet; 2016 Jul; 24(7):1022-8. PubMed ID: 26626313
[TBL] [Abstract][Full Text] [Related]
29. Power and sample size for GEE analysis of incomplete paired outcomes in 2 × 2 crossover trials.
Tang Y
Pharm Stat; 2021 Jul; 20(4):820-839. PubMed ID: 33738918
[TBL] [Abstract][Full Text] [Related]
30. A comparison of the generalized estimating equation approach with the maximum likelihood approach for repeated measurements.
Park T
Stat Med; 1993 Sep; 12(18):1723-32. PubMed ID: 8248664
[TBL] [Abstract][Full Text] [Related]
31. Modeling the Dependence Structure in Genome Wide Association Studies of Binary Phenotypes in Family Data.
Seal S; Boatman JA; McGue M; Basu S
Behav Genet; 2020 Nov; 50(6):423-439. PubMed ID: 32804302
[TBL] [Abstract][Full Text] [Related]
32. Small sample GEE estimation of regression parameters for longitudinal data.
Paul S; Zhang X
Stat Med; 2014 Sep; 33(22):3869-81. PubMed ID: 24797886
[TBL] [Abstract][Full Text] [Related]
33. Genetic factors associated with gemcitabine pharmacokinetics, disposition, and toxicity.
Knights J; Sato Y; Kaniwa N; Saito Y; Ueno H; Ramanathan M
Pharmacogenet Genomics; 2014 Jan; 24(1):15-25. PubMed ID: 24225399
[TBL] [Abstract][Full Text] [Related]
34. Shrinkage estimation for robust and efficient screening of single-SNP association from case-control genome-wide association studies.
Luo S; Mukherjee B; Chen J; Chatterjee N
Genet Epidemiol; 2009 Dec; 33(8):740-50. PubMed ID: 19434716
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of methodology for the analysis of 'time-to-event' data in pharmacogenomic genome-wide association studies.
Syed H; Jorgensen AL; Morris AP
Pharmacogenomics; 2016 Jun; 17(8):907-15. PubMed ID: 27248145
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells.
You L; Chang D; Du HZ; Zhao YP
Biochem Biophys Res Commun; 2011 Apr; 407(1):1-6. PubMed ID: 21316338
[TBL] [Abstract][Full Text] [Related]
37. Efficient generalized least squares method for mixed population and family-based samples in genome-wide association studies.
Li J; Yang J; Levin AM; Montgomery CG; Datta I; Trudeau S; Adrianto I; McKeigue P; Iannuzzi MC; Rybicki BA
Genet Epidemiol; 2014 Jul; 38(5):430-8. PubMed ID: 24845555
[TBL] [Abstract][Full Text] [Related]
38. Estimating heterogeneity in random effects models for longitudinal data.
Lemenuel-Diot A; Mallet A; Laveille C; Bruno R
Biom J; 2005 Jun; 47(3):329-45. PubMed ID: 16053257
[TBL] [Abstract][Full Text] [Related]
39. SNP_NLMM: A SAS Macro to Implement a Flexible Random Effects Density for Generalized Linear and Nonlinear Mixed Models.
Vock DM; Davidian M; Tsiatis AA
J Stat Softw; 2014 Jan; 56():2. PubMed ID: 24688453
[TBL] [Abstract][Full Text] [Related]
40. Clinical pharmacology and pharmacogenetics of gemcitabine.
Wong A; Soo RA; Yong WP; Innocenti F
Drug Metab Rev; 2009; 41(2):77-88. PubMed ID: 19514966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
